"This survey investigates the use of statins in individuals older than 79 years by vascular disease.
There is little randomized evidence to guide the use of statins (HMG-CoA reductase inhibitors) in very elderly individuals (>79 years).1,2 Despite this, the very elderly have the highest rate of statin use in the United States.3 Given that few studies have investigated the use of statins among this population in a longitudinal manner by vascular disease, we set out to do so."
Aucun commentaire:
Enregistrer un commentaire